Navigation Links
51st Interscience Conference on Antimicrobial Agents and Chemotherapy
Date:8/3/2011

News media registration for the annual infectious diseases meeting of the American Society for Microbiology (ASM) is now open. The 51st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) will be held September 17-20, 2011 at the McCormick Place Convention Center in Chicago, Illinois.

Known as the preeminent world meeting for presenting new information on clinical and basic research in infectious diseases and anti-infective therapy, ICAAC has also traditionally served as a forum for the introduction of new antimicrobial agents. It is the largest infectious disease meeting held in the United States.

The opening keynote session will focus on the the topics of the resurgence of gram-negative bacterial infections, new issues in vaccine development and the role of human genetics in infectious disease risk.

The ICAAC Lecture, by Albert D. Osterhaus of Erasmus, MC in Rotterdam, the Netherlands will focus on emerging viral infections.

The ASM Office of Communications will host a full-service press room with Internet access, telelphones, computers, photocopy and fax machines, and refreshments. Streaming audio and video of daily press conferences will be available over the Internet for reporters covering from a distance. Programs and abstracts, as well as an embargoed online press kit featuring tipsheets, lay-summaries of selected presentations and the press conference schedule will be available in advance of the meeting. For media registration and housing please go to http://www.icaac.org/index.php/newsroom.


'/>"/>

Contact: Jim Sliwa
jsliwa@asmusa.org
202-942-9297
American Society for Microbiology
Source:Eurekalert

Page: 1

Related biology news :

1. 2011 Technologies for Critical Incident Preparedness Conference & Expo
2. NYU Langone Medical Centers tip sheet to the 2011 Alzheimers Association International Conference
3. AACR hosts Frontiers in Basic Cancer Research Conference in San Francisco
4. TGen presents lung cancer studies at Amsterdam conference
5. First whole-genome lung cancer study by TGen and Virginia G. Piper Cancer Center set for conference
6. 19th Conference of the International Society for Sexually Transmitted Disease Research
7. New York Academy of Sciences hosts a conference on rare disease Shwachman-Diamond Syndrome
8. Global strategy for plant conservation conference to take place at the Missouri Botanical Garden
9. FASEB announces new client: The International Conference on Human Immunity to Tuberculosis
10. Nobel Laureate to speak at American Chemical Society green chemistry conference
11. Stevens conference explores latest innovations in antimicrobial biomaterials research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/13/2016)... , April 13, 2016  IMPOWER physicians supporting ... are setting a new clinical standard in telehealth thanks ... By leveraging the higi platform, IMPOWER patients can routinely ... pulse and body mass index, and, when they opt ... and convenient visit to a local retail location at ...
(Date:3/29/2016)... 2016 LegacyXChange, Inc. (OTC: ... SelectaDNA/CSI Protect are pleased to announce our successful effort ... variety of writing instruments, ensuring athletes signatures against counterfeiting ... from athletes on LegacyXChange will be assured of ongoing ... Bill Bollander , CEO states, "By ...
(Date:3/22/2016)... and SANDY, Utah , March ... operates the highest sample volume laboratory in ... and UNIConnect, leaders in clinical sequencing informatics and molecular ... of a project to establish the informatics infrastructure for ... NSO has been contracted by the Ontario Ministry ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... , ... June 23, 2016 , ... ... release of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering ... retention in this eBook by providing practical tips, tools, and strategies for clinical ...
(Date:6/23/2016)... June 23, 2016 /PRNewswire/ - FACIT has announced ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" ... commercialization of a portfolio of first-in-class WDR5 inhibitors ... such as WDR5 represent an exciting class of ... precision medicine for cancer patients. Substantial advances have ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... YM (Yeast and Mold) microbial test has received AOAC Research Institute approval 061601. ... microbial tests introduced last year,” stated Bob Salter, Vice President of Regulatory and ...
(Date:6/23/2016)... 23, 2016   EpiBiome , a precision microbiome ... in debt financing from Silicon Valley Bank (SVB). The ... to advance its drug development efforts, as well as ... "SVB has been an incredible strategic partner to ... traditional bank would provide," said Dr. Aeron Tynes ...
Breaking Biology Technology: